Browse 10 Pharmaceutical companies funded by Matrix Partners China. See funding amounts, founder contacts, and investment details.
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.
Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.
Alioth focuses on the development and application of technical products for pharmaceutical process technology.
D3 Bio is a biotechnology company focusing on the development and registration of medicines.
Ennovabio is a Chinese drug developer that focuses on creating drugs targeting brain glioma.
Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on small molecule drugs for cancer and autoimmune diseases.
Triastek is a 3D printing technology startup.
Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Nutshell Therapeutics invents small molecules in the realm of drug discovery fostered by protein dynamics.
View all companies funded by Matrix Partners China across every industry and funding stage.
View Full Matrix Partners China Portfolio